Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Walton

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
Gastroenterology|August 28, 1998
Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study groupS B Hanauer, M Robinson, R Pruitt, et al.
International Journal of Pharmaceutics|September 14, 2017
The influence of hydroalcoholic media on the performance of Grewia polysaccharide in sustained release tabletsE I Nep, M H Mahdi, A O Adebisi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 19, 2017
Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task ForceJohn H Powers, Donald L Patrick, Marc K Walton, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
DIA's Adaptive Design Scientific Working Group (ADSWG): Best Practices Case Studies for "Less Well-understood" Adaptive DesignsEva Miller, Paul Gallo, Weili He, et al.
American Journal of Human Genetics|November 1, 1995
Physical mapping of the holoprosencephaly critical region in 21q22.3, exclusion of SIM2 as a candidate gene for holoprosencephaly, and mapping of SIM2 to a region of chromosome 21 important for Down syndromeM Muenke, L J Bone, H F Mitchell, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 12, 2014
Commonalities and challenges in the development of clinical trial measures in neurologyJesse M Cedarbaum, Diane Stephenson, Richard Rudick, et al.
Diabetes, Obesity & Metabolism|March 1, 2017
Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trialsBruce Neal, Vlado Perkovic, Kenneth W Mahaffey, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 23, 2015
Erratum to: Commonalities and Challenges in the Development of Clinical Trial Measures in NeurologyJesse M Cedarbaum, Diane Stephenson, Richard Rudick, et al.
Elife|October 19, 2020
Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2AAntonietta Franco, Xiawei Dang, Emily K Walton, et al.
The Journal of Heart Valve Disease|October 27, 2009
Trends in mitral valve surgery: a single practice experienceJ Scott Rankin, Calvin A Burrichter, Melissa K Walton-Shirley, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
Gastroenterology|August 28, 1998
Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study groupS B Hanauer, M Robinson, R Pruitt, et al.
International Journal of Pharmaceutics|September 14, 2017
The influence of hydroalcoholic media on the performance of Grewia polysaccharide in sustained release tabletsE I Nep, M H Mahdi, A O Adebisi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 19, 2017
Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task ForceJohn H Powers, Donald L Patrick, Marc K Walton, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
DIA's Adaptive Design Scientific Working Group (ADSWG): Best Practices Case Studies for "Less Well-understood" Adaptive DesignsEva Miller, Paul Gallo, Weili He, et al.
American Journal of Human Genetics|November 1, 1995
Physical mapping of the holoprosencephaly critical region in 21q22.3, exclusion of SIM2 as a candidate gene for holoprosencephaly, and mapping of SIM2 to a region of chromosome 21 important for Down syndromeM Muenke, L J Bone, H F Mitchell, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 12, 2014
Commonalities and challenges in the development of clinical trial measures in neurologyJesse M Cedarbaum, Diane Stephenson, Richard Rudick, et al.
Diabetes, Obesity & Metabolism|March 1, 2017
Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trialsBruce Neal, Vlado Perkovic, Kenneth W Mahaffey, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 23, 2015
Erratum to: Commonalities and Challenges in the Development of Clinical Trial Measures in NeurologyJesse M Cedarbaum, Diane Stephenson, Richard Rudick, et al.
Elife|October 19, 2020
Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2AAntonietta Franco, Xiawei Dang, Emily K Walton, et al.
The Journal of Heart Valve Disease|October 27, 2009
Trends in mitral valve surgery: a single practice experienceJ Scott Rankin, Calvin A Burrichter, Melissa K Walton-Shirley, et al.
Pageof 17